NIH to test GSK, Brii drugs To view this email as a web page,
click here Pfizer antes up on the feds' vaccine criticism, saying Warp Speed has everything it's asked for—and more Federal guidance enables employers to mandate workers get COVID-19 vaccine After Lilly's failure, NIH tests GSK/Vir and Brii COVID-19 drugs in hospitalized patients From weaponized AI to threats against the vaccine rollout, here are 6 cybersecurity trends to watch in 2021 Healthcare roundup: CVS, Walgreens begin distributing vaccine in long-term care facilities Biopharma roundup: Pfizer, Moderna's EU shot prices revealed; GSK, Vir and Brii tapped for new NIH antibody trials Mesoblast craters as Novartis-backed COVID-19 drug flunks trial Philips puts down $2.8B for BioTelemetry and its wearable heart monitors Featured Story | By Fraiser Kansteiner After federal officials took aim at Pfizer's pandemic vaccine work Wednesday, Pfizer hit back. The drugmaker said its manufacturing is right on track, delivery commitments have been met and, what's more, it has millions more doses on warehouse shelves. All it needs are shipping instructions from the feds. read more |
| |
|---|
|
Top Stories By Robert King New federal guidance gives employers the authority to mandate workers take COVID-19 vaccines as hospital workers become the first to get precious few doses. read more By Phil Taylor The NIH has started dosing patients in new trials of antibodies from GlaxoSmithKline/Vir Biotechnology and Brii Biosciences in patients hospitalized with COVID-19—hoping to succeed where Eli Lilly’s LY-CoV555 failed a few weeks ago. read more By Heather Landi Could 2021 be the year that healthcare finally gets smart about cybersecurity? Many in the industry say real change needs to happen as the situation has become a matter of life and death. Here are six threats and trends to watch in 2021. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more By Eric Sagonowsky,Angus Liu,Kyle Blankenship,Conor Hale,Fraiser Kansteiner A Belgian official divulged the EU price tags for Pfizer and Moderna's shots. The NIH launched a trial of GSK and Vir's antibody, plus an antibody combo from Brii. The FDA cleared a home version of Abbott's rapid antigen test. COVAX secured some 2 billion vaccine doses. And Vice Pres. Pence got vaccinated on television. read more By Phil Taylor Australian biotech Mesoblast has been riding high on expectations for its COVID-19 treatment, licensed to Novartis, but fell back to Earth after it said a phase 3 trial of the cell therapy was a bust. read more By Conor Hale Philips aims to broaden the reach of its digital patient monitoring platforms, from inside the hospital out to the home, through a $2.8 billion acquisition deal for BioTelemetry and its wearable heart-tracking devices. read more |
|
